Login
$GALT
$3.38 +$0.19 (5.96%) Close

$GALT 4 SEC Filings

Filed On Filing
04 Aug 2026 Form 4: Uihlein Richard E, Director

Received 34,376,167 shares by exercise or conversion ($106M)

16 Jul 2026 Form 4: Jamil Khurram, Chief Medical Officer

Received 16,250 shares by exercise or conversion ($49.4K) · Sold 16,250 shares ($83.3K)

30 Jun 2026 Form 4: Shlevin Harold H., Director

Received 7,732 shares by exercise or conversion ($9.51K) · Sold 7,732 shares ($38.7K) · Received 22,268 shares by exercise or conversion ($27.4K) · 1 more

30 Jun 2026 Form 4: Jamil Khurram, Chief Medical Officer

Received 4,570 shares by exercise or conversion ($10.8K) · Sold 4,570 shares ($22.9K) · Received 47,467 shares by exercise or conversion ($119K) · 1 more

25 Jun 2026 Form 4: Jamil Khurram, Chief Medical Officer

Received 7,557 shares by exercise or conversion ($9.3K) · Sold 7,557 shares ($23.7K)

28 May 2026 Form 4: Jamil Khurram, Chief Medical Officer

Received 568 shares by exercise or conversion ($699) · Sold 568 shares ($1.76K)

17 Mar 2026 Form 4: Brem Henry, Director

Granted 60,000 Stock option (right to buy)

09 Feb 2026 Form 4: Eldred Kary, Director

Bought 300 shares ($810)

21 Jan 2026 Form 4: Carson Benjamin Sr, Director

Granted 60,000 Stock option (right to buy)

21 Jan 2026 Form 4: Zordani Richard A. Jr., Director

Granted 60,000 Stock option (right to buy)

21 Jan 2026 Form 4: Jamil Khurram, Chief Medical Officer

Granted 65,000 Stock option (right to buy) · Granted 100,000 Restricted Stock Unit

21 Jan 2026 Form 4: Freeman Kevin D, Director

Granted 60,000 Stock option (right to buy)

21 Jan 2026 Form 4: Eldred Kary, Director

Granted 60,000 Stock option (right to buy)

21 Jan 2026 Form 4: Lewis Joel, Director

Granted 84,000 Stock option (right to buy) · Granted 120,000 Restricted Stock Unit

21 Jan 2026 Form 4: Callicutt Jack W, Chief Financial Officer

Granted 65,000 Stock option (right to buy) · Granted 100,000 Restricted Stock Unit

21 Jan 2026 Form 4: Shlevin Harold H., Director

Granted 60,000 Stock option (right to buy)

21 Jan 2026 Form 4: Omenn Gilbert S, Director

Granted 60,000 Stock option (right to buy)

21 Jan 2026 Form 4: Amelio Gilbert F, Director

Granted 60,000 Stock option (right to buy)

21 Jan 2026 Form 4: Schwartz Elissa J., Director

Granted 60,000 Stock option (right to buy)

21 Jan 2026 Form 4: Uihlein Richard E, Director

Received 13,158 shares as a grant or award ($40K) · Granted 60,000 Stock option (right to buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support